Dr. Prenner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Plum Street
Suite 600
New Brunswick, NJ 08901Phone+1 732-220-1600Fax+1 732-220-1603
Education & Training
- University of Pennsylvania Health System/Scheie Eye InstituteResidency, Ophthalmology, 1999 - 2002
- Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 1998 - 1999
- Stony Brook University Health Sciences Center School of MedicineClass of 1998
Certifications & Licensure
- NJ State Medical License 2004 - 2025
- MI State Medical License 2002 - 2006
- PA State Medical License 2000 - 2002
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2014
- Top Doctors: New York Metro Area Castle Connolly, 2014
- New York Magazine: Top Doctors Castle Connolly, 2013-2014
- Join now to see all
Publications & Presentations
PubMed
- 32 citationsFrequency of Urgent or Emergent Vitreoretinal Surgical Procedures in the United States During the COVID-19 Pandemic.Mark P. Breazzano, Archana A Nair, J. Fernando Arevalo, Mark R. Barakat, Audina M. Berrocal
JAMA Ophthalmology. 2021-04-01 - 122 citationsDisease Burden in the Treatment of Age-Related Macular Degeneration: Findings From a Time-and-Motion StudyJonathan L. Prenner, Lawrence S. Halperin, Catherine Rycroft, Susan Hogue, Zinaria Williams Liu
American Journal of Ophthalmology. 2015-10-01 - 68 citationsA Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular DegenerationGlenn J. Jaffe, Dean Eliott, John A. Wells, Jonathan L. Prenner, András Papp
Ophthalmology. 2016-01-01
Press Mentions
- CLINICAL TRIAL DOWNLOAD: Two-Year Brolucizumab DataMarch 1st, 2019
- The Retina Fellowship Match: How to Rank ProgramsDecember 3rd, 2018
- EyeBio Announces First Patients Dosed in Phase 1b/2 Trial of Restoret in Wet AMD and DMEJune 16th, 2023
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: